Canada markets open in 9 hours 24 minutes

Paratek Pharmaceuticals, Inc. (PRTK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.7300-0.1700 (-8.95%)
At close: 04:00PM EDT
1.8001 +0.07 (+4.05%)
After hours: 04:04PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 105.14M
Enterprise Value 283.10M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.75
Price/Book (mrq)N/A
Enterprise Value/Revenue 2.20
Enterprise Value/EBITDA -7.07

Trading Information

Stock Price History

Beta (5Y Monthly) 1.57
52-Week Change 3-78.98%
S&P500 52-Week Change 3-6.07%
52 Week High 311.2400
52 Week Low 31.6950
50-Day Moving Average 32.5020
200-Day Moving Average 34.0681

Share Statistics

Avg Vol (3 month) 3560.39k
Avg Vol (10 day) 3407.3k
Shares Outstanding 554.48M
Implied Shares Outstanding 6N/A
Float 843.57M
% Held by Insiders 116.58%
% Held by Institutions 153.96%
Shares Short (Apr 28, 2022) 45.6M
Short Ratio (Apr 28, 2022) 47.63
Short % of Float (Apr 28, 2022) 410.95%
Short % of Shares Outstanding (Apr 28, 2022) 410.27%
Shares Short (prior month Mar 30, 2022) 45.38M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 28, 2014
Ex-Dividend Date 4Oct 30, 2014
Last Split Factor 21:12
Last Split Date 3Oct 30, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -42.32%
Operating Margin (ttm)-29.31%

Management Effectiveness

Return on Assets (ttm)-15.41%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)138.6M
Revenue Per Share (ttm)2.78
Quarterly Revenue Growth (yoy)51.30%
Gross Profit (ttm)78.27M
EBITDA -40.2M
Net Income Avi to Common (ttm)-58.65M
Diluted EPS (ttm)-1.1780
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)79.05M
Total Cash Per Share (mrq)1.45
Total Debt (mrq)257.61M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.62
Book Value Per Share (mrq)-2.65

Cash Flow Statement

Operating Cash Flow (ttm)-45.87M
Levered Free Cash Flow (ttm)-30.76M